Zepbound® Medication

Discover Zepbound® by Eli Lilly, its benefits, studies, and potential side effects for informed choices.

Zepbound® (tirzepatide) is a groundbreaking FDA-approved, once-weekly injectable medication for chronic weight management in adults. Developed by Eli Lilly and approved in late 2023, Zepbound is the first and only medication that combines dual-incretin hormone action—offering superior results compared to earlier GLP-1 therapies like Wegovy®.

Zepbound is approved for adults with:

  • A BMI of 30 or greater (obesity)

  • Or a BMI of 27 or greater (overweight) with at least one weight-related medical condition such as type 2 diabetes, high blood pressure, or high cholesterol

Zepbound® for Weight Loss – The New Standard in Obesity Treatment

How Zepbound® Works

Zepbound contains tirzepatide, a dual agonist of:

  • GLP-1 (glucagon-like peptide-1)

  • GIP (glucose-dependent insulinotropic polypeptide)

This “twin incretin” mechanism enhances the body’s ability to:

  • Regulate blood sugar

  • Control appetite

  • Delay gastric emptying

  • Boost fat metabolism

  • Improve insulin sensitivity

The result is faster, more powerful weight loss with additional metabolic benefits compared to GLP-1-only medications like semaglutide.

Efficacy and Results

Zepbound has shown unmatched weight loss results in clinical trials, with participants losing up to 22.5% of their starting body weight over 72 weeks.

Key outcomes from the SURMOUNT-1 study:

  • 15 mg tirzepatide: Average of 52 lbs lost (~22.5% of body weight)

  • Compared to placebo: ~5 lbs lost (~2.4%)

  • More than 80% of users lost ≥15% of their body weight

This makes Zepbound the most effective FDA-approved weight loss medication currently available.

a bottle of zepbound vaccine with a purple and white label
a bottle of zepbound vaccine with a purple and white label
Zepbound®

This is for exam and prescription only and we will assist you with getting your medications directly from the Eli Lilly Direct Pharmacy

a bottle of tirzepatide
a bottle of tirzepatide
Compounded Tirzepatide Weight Loss Injection Kit

Compounded tirzepatide is a breakthrough weight loss medication that uses the same active ingredient found in Zepbound® and Mounjaro®.

COMPANY

Support

650-6-SKINNY

© 2026. All rights reserved.

LEARN

24/7 Website Live Chat

Call or Text

Made Ya Skinny

Magnolia

Made Ya Skinny, LLC is a Texas-licensed medical practice and med spa. Medical services within Texas are provided directly by Made Ya Skinny, LLC through licensed medical professionals.

For patients located outside of Texas, Made Ya Skinny, LLC partners with independent, licensed healthcare providers to deliver medical services via telehealth. Medical services in those states are rendered by independent providers in accordance with applicable state laws.

Our medical weight loss programs are overseen by licensed providers and tailored to each patient’s individual needs. Depending on medical history and clinical evaluation, treatment plans may include weekly injectable therapies as part of a provider-directed weight management program. Treatment recommendations are determined only after a medical consultation and are not appropriate for every patient.

Certain individualized treatment plans may involve compounded medications prepared by licensed compounding pharmacies pursuant to a patient-specific prescription. Compounded medications are not FDA-approved.

Our physician-directed compounded programs do not use FDA-approved branded GLP-1 medications.

Actual medication form and appearance may differ from what is shown.

New Patient Book a Reservation

Weight Management